Conference Proceedings

The immunomodulatory potential of denosumab in breast cancer: results from D-BEYOND, a window of opportunity trial evaluating a RANK-ligand (RANKL) inhibitor and its biological effects in young pre-menopausal women diagnosed with early breast cancer

B Nguyen, M Marion, R Salgado, D Venet, P Vuylsteke, L Polastro, H Wieldiers, P Simon, G Lindeman, D Larsimont, G Van den Eynden, C Velghe, F Rothe, S Garaud, S Michiels, K Willard-Gallo, HA Azim, S Loi, M Piccart, C Sotiriou

CANCER RESEARCH | AMER ASSOC CANCER RESEARCH | Published : 2019